New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 21, 2013
10:10 EDTHURN, JDSU, TTI, REGI, IRWD, VIPS, CXO, FNSR, SGYP, MKGAY, ICPT, BKW, MRC, WEN, SCMP, PTN, PICO, XOM, AMRN, DAR, IT, CVXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Amarin (AMRN) initiated with a Perform at Oppenheimer... Chevron (CVX) initiated with an Outperform at Wells Fargo... Darling (DAR) initiated with an Outperform at Wedbush... Exxon Mobil (XOM) initiated with a Market Perform at Wells Fargo... Gartner (IT) initiated with a Buy at Stifel... Intercept (ICPT) initiated with an Outperform at Oppenheimer... Ironwood (IRWD) initiated with an Outperform at Credit Suisse... Merck KGaA (MKGAY) initiated with a Sell at Goldman... Palatin Tech (PTN) initiated with an Overweight at Piper Jaffray... Renewable Energy (REGI) initiated with an Outperform at Wedbush... Sucampo (SCMP) initiated with a Neutral at Credit Suisse... Synergy Pharmaceuticals (SGYP) initiated with an Outperform at Credit Suisse... Tetra Technologies (TTI) initiated with an Equal Weight at Stephens... Wendy's (WEN) initiated with a Market Perform at Wells Fargo... Finisar (FNSR) initiated with a Buy at Craig-Hallum... JDSU (JDSU) initiated with a Buy at Craig-Hallum... MRC Global (MRC) initiated with a Buy at Maxim... Concho Resources (CXO) re-initiated with a Buy at BofA/Merrill... Huron (HURN) initiated with a Buy at Stifel... Burger King (BKW) initiated with a Market Perform at Wells Fargo... PICO Holdings (PICO) initiated with an Outperform at Northland Securities... Vipshop (VIPS) initiated with a Buy at Citigroup.
News For AMRN;CVX;DAR;XOM;IT;ICPT;IRWD;PTN;MKGAY;REGI;SCMP;SGYP;TTI;WEN;FNSR;JDSU;MRC;CXO;HURN;BKW;VIPS;PICO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
May 13, 2015
11:28 EDTVIPSStocks with call strike movement; TWTR JCP
Subscribe for More Information
09:57 EDTVIPSVipshop says allegations on independence of board, audit firm unfounded
Vipshop issued a statement in response to recent allegations made by a few short sellers, stating in part: "The allegations also challenge the independence of the company's board and its audit firm. This allegation is unfounded. As required by U.S. securities laws and the NYSE listing requirements, the board of directors of the company performs annual assessments of director independence, and the independent directors identified in the company's 2014 annual report on Form 20-F were determined to have met the independence requirements set forth in applicable laws and listing rules."
09:56 EDTVIPSEquity options with increasing volume
Subscribe for More Information
09:55 EDTVIPSVipshop says short seller allegations 'unfounded, contain numerous errors'
Subscribe for More Information
08:36 EDTJDSUJDSU signs definitive agreement with Amada Holdings
Subscribe for More Information
07:35 EDTPTNPalatin Tech reports Q3 EPS (7c), consensus (6c)
Subscribe for More Information
May 12, 2015
15:01 EDTVIPSVipshop volatility increases into Q1 and outlook
Subscribe for More Information
14:53 EDTVIPSVipshop mentioned cautiously by Seeking Alpha PRO contributor
Seeking Alpha contributor Mithra Forensic Research is initiating coverage on Vipshop with a Strong Sell / Sell Short recommendation and said its forensic models suggest that the firm has manipulated sales, receivables, profit and other asset accounts. Reference Link
12:42 EDTVIPSOptions with increasing put volume and implied volatility
Options with increasing put volume and implied volatility: ESI VIPS WETF
07:52 EDTIRWDLeerink to hold a tour
Subscribe for More Information
May 11, 2015
16:48 EDTSGYPSynergy Pharmaceuticals reports Q1 EPS (28c), consensus (27c)
Cash, cash equivalents and available-for-sale securities balance as of March 31, 2015 was $178.6M, as compared to $196.4M on December 31, 2014.
16:34 EDTSCMPSucampo enters into licensing agreement with Harbin Gloria Pharmaceuticals
Sucampo announced that it entered into an exclusive license, development, commercialization and supply agreement with Harbin Gloria Pharmaceuticals for AMITIZA in the People's Republic of China. Through this agreement, Sucampo has granted Gloria the rights to develop and commercialize AMITIZA in China, subject to regulatory approval of the product by the China Food and Drug Administration, or CFDA. Under the terms of the agreement, Sucampo will receive an upfront payment of $1.5M and a milestone payment from Gloria. The upfront payment will consist of $1M within 30 days of signing the agreement and $500,000 within 30 days of investigational new drug application approval in China. Sucampo will also be eligible for an additional milestone payment upon the occurrence of a regulatory or alternatively a commercial milestone event. Sucampo will be the exclusive supplier of AMITIZA to Gloria at an agreed-upon supply price. The term of this agreement is 13 years with renewal terms. Gloria will be responsible for all development activities and costs. In addition, Gloria will be responsible for all commercialization and regulatory activities in China.
13:28 EDTXOM, CVXOPEC sees oil at around $76 a barrel in 2025, WSJ says
Subscribe for More Information
10:01 EDTXOMExxon Mobil announces Cold Lake project expansion begins production on schedule
Subscribe for More Information
07:48 EDTTTITetra Technologies still liked at Cowen due to turnaround potential
Subscribe for More Information
06:10 EDTICPTIntercept reports Q1 EPS ($1.78), consensus ($1.69)
Subscribe for More Information
May 8, 2015
07:33 EDTTTITetra Technologies reports Q1 Fluids revenue $99.28M
Reports Q1 Production Testing revenue $37.1M. Reports Q1 Compressoin Division revenue $102.89M.
07:31 EDTTTITetra Technologies reports Q1 EPS (3c), consensus (5c)
Subscribe for More Information
07:20 EDTVIPSVipshop May volatility elevated into Q1 and outlook
Vipshop May call option implied volatility is at 70, June is at 37, August is at 35; compared to its 90-day average of 49, suggesting large near term price movement into the expected release of Q1 results on May 14.
06:02 EDTAMRNAmarin reports Q1 adjusted EPS (16c), consensus (11c)
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use